Atlas Trials

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

Clinical trial NCT01338831 · COMPLETED

Trial details

NCT number
NCT01338831
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Castration-resistant Prostate CancerMetastatic Breast CancerUterine Leiomyoma
Start date
2011-09-01
Primary completion
2014-03-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.